[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $immunitybioibrxus ImmunityBio announces positive Phase X trial results for its cancer immunotherapy, sparking investor optimism. Stock sees a significant uptick following the news. ### About $immunitybioibrxus ImmunityBio, Inc. is a clinical-stage immunotherapy company developing therapies for cancer and infectious diseases.
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ImmunityBio announces positive Phase X trial results for its cancer immunotherapy, sparking investor optimism. Stock sees a significant uptick following the news.
ImmunityBio, Inc. is a clinical-stage immunotherapy company developing therapies for cancer and infectious diseases.
/topic/$immunitybioibrxus